Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Rojo

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
BMC Public Health|July 8, 2022
Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherenceSheila Fernández-Luis, Maria Grazia Lain, Miquel Serna-Pascual, et al.
The Pediatric Infectious Disease Journal|October 9, 2024
Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital CytomegalovirusSerena Villaverde, Roberto Pedrero-Tomé, Vassiliki Papaevangelou, et al.
Eclinicalmedicine|April 22, 2026
Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trialTom G Jacobs, Vivian Mumbiro, John Tembo, et al.
Scientific Reports|October 29, 2024
Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countriesElena Morrocchi, Giuseppe R Pascucci, Nicola Cotugno, et al.
Pediatric Pulmonology|October 11, 2021
Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in SpainEnrique Otheo, Mario Rodríguez, Cinta Moraleda, et al.
The Pediatric Infectious Disease Journal|February 15, 2024
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory DiseasesSophya Yeoh, Diego Estrada-Rivadeneyra, Heather Jackson, et al.
Nature Medicine|February 5, 2025
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
The New England Journal of Medicine|November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of AgeEmmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
Nature Medicine|June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
The New England Journal of Medicine|December 29, 2021
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in ChildrenAnna Turkova, Ellen White, Hilda A Mujuru, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
BMC Public Health|July 8, 2022
Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherenceSheila Fernández-Luis, Maria Grazia Lain, Miquel Serna-Pascual, et al.
The Pediatric Infectious Disease Journal|October 9, 2024
Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital CytomegalovirusSerena Villaverde, Roberto Pedrero-Tomé, Vassiliki Papaevangelou, et al.
Eclinicalmedicine|April 22, 2026
Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trialTom G Jacobs, Vivian Mumbiro, John Tembo, et al.
Scientific Reports|October 29, 2024
Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countriesElena Morrocchi, Giuseppe R Pascucci, Nicola Cotugno, et al.
Pediatric Pulmonology|October 11, 2021
Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in SpainEnrique Otheo, Mario Rodríguez, Cinta Moraleda, et al.
The Pediatric Infectious Disease Journal|February 15, 2024
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory DiseasesSophya Yeoh, Diego Estrada-Rivadeneyra, Heather Jackson, et al.
Nature Medicine|February 5, 2025
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
The New England Journal of Medicine|November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of AgeEmmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
Nature Medicine|June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
The New England Journal of Medicine|December 29, 2021
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in ChildrenAnna Turkova, Ellen White, Hilda A Mujuru, et al.
Pageof 15